Wolfe, Andrew Lerner

Publications

Sort by

Co-Author Network

selected publications

Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity. PloS one. 2025 Academic Article GET IT
Times cited: 1
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine. Proceedings of the National Academy of Sciences of the United States of America. 2025 Academic Article GET IT
Times cited: 1
Selective targeting of oncogenic KRAS G12D using peptide nucleic acid oligomers attached to cell-penetrating peptides. 2025 GET IT
IMPlications of IMP2 in RNA Biology and Disease. International journal of molecular sciences. 2025 Review GET IT
Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function. 2024 GET IT
Cadherin-17 as a target for the immunoPET of adenocarcinoma. European journal of nuclear medicine and molecular imaging. 2024 Academic Article GET IT
Times cited: 3
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance. Current oncology (Toronto, Ont.). 2024 Review GET IT
Times cited: 16
Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability. Molecular & cellular oncology. 2021 Academic Article GET IT
Times cited: 7
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. Proceedings of the National Academy of Sciences of the United States of America. 2021 Academic Article GET IT
Times cited: 36
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer. Communications biology. 2021 Academic Article GET IT
Times cited: 28
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy. Cancers. 2021 Academic Article GET IT
Times cited: 15
Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity. Immunity. 2017 Academic Article GET IT
Times cited: 52
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Science signaling. 2014 Academic Article GET IT
Times cited: 41
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature. 2014 Academic Article GET IT
Times cited: 509
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell. 2011 Academic Article GET IT
Times cited: 151
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. The Journal of experimental medicine. 2011 Academic Article GET IT
Times cited: 101
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nature genetics. 2011 Academic Article GET IT
Times cited: 238
Mouse models of cancer as biological filters for complex genomic data. Disease models & mechanisms. 2010 Academic Article GET IT
Times cited: 6
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature cell biology. 2010 Academic Article GET IT
Times cited: 312

more ...

less ...

Background

education and training

Ph.D., Weill Cornell Graduate School of Medical Sciences 2014
B.Sc., University of California, Los Angeles 2007

Contact

full name

Andrew Lerner Wolfe

primary email

alw2011@med.cornell.edu

VIVO Weill Cornell Medical College

Andrew Lerner Wolfe Adjunct Assistant Professor of Pharmacology

Publications

selected publications

Background

education and training

Contact

full name

primary email